{"schema_version":"secwatch.filing_event.v1","accession":"0000010795-23-000072","form_type":"8-K","ticker":"BDX","cik":"0000010795","company_name":"BECTON DICKINSON & CO","filed_at":"2023-08-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.090986+00:00","generated_at":"2026-06-12T07:07:39.018658+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"BD Q3 revenue $4.88B up 5.1%, adjusted EPS $2.96 up 11.3%, raises FY revenue guidance","bullets":["Revenue of $4.88B, up 5.1% as reported, 6.3% currency-neutral; base revenue growth 6.7% as reported.","GAAP diluted EPS $1.36; adjusted diluted EPS $2.96 vs $2.66 YoY, up 11.3%.","Raised full-year base organic revenue growth guidance; maintained full-year adjusted EPS guidance.","Received FDA 510(k) clearance for updated BD Alaris Infusion System, a key BD 2025 milestone.","Completed sale of Surgical Instrumentation platform to STERIS for $540M."],"urls":{"canonical":"https://secwatch.observer/filing/0000010795-23-000072","json":"https://secwatch.observer/filing/0000010795-23-000072.json","markdown":"https://secwatch.observer/filing/0000010795-23-000072.md","text":"https://secwatch.observer/filing/0000010795-23-000072.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/10795/000001079523000072/0000010795-23-000072-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/10795/000001079523000072/bdx-20230803.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T07:07:39.018658+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"22f7224379660c121edb78850b0b28bbfb1d3eda","claim":"BECTON DICKINSON & CO reported financial results for third quarter of fiscal 2023, which ended June 30, 2023.","evidence_excerpt":"On August 3, 2023, Becton, Dickinson and Company (“BD”) issued a press release announcing its financial results for its third fiscal quarter ending June 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/10795/000001079523000072/0000010795-23-000072-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter of fiscal 2023, which ended June 30, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}